The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InOrganigram Global Inc. has entered into a subscription agreement with British American Tobacco (BAT) for a C$65.2 million private placement investment. The capital injection is specifically designated to fund the previously announced acquisition of Sanity Group GmbH. The investment is being made through a wholly-owned subsidiary of BAT, further solidifying the strategic alliance between the two companies. This funding provides Organigram with the necessary financial resources to execute its international expansion and M&A strategy. Market analysts view this move as a significant endorsement of Organigram’s growth potential within the evolving cannabis sector. The partnership with a global giant like BAT is expected to enhance Organigram's market positioning and operational scale.